Elucidation on mechanisms of vanilloid and cannabinoid functions in the urogenital afferent neurotransmissions

阐明香草酸和大麻素在泌尿生殖传入神经传递中的功能机制

基本信息

项目摘要

Backaround of the study on the significance of epithelial sodium channel (ENaC) in the mechanism inducing overactive bladder :Overactive bladder (OAB) is the symptom-based syndrome which was newly defined by the International Continence Society in 2002, and is a storage dysfunction exhibiting urinary urgency as an essential symptom. The mechanism inducing urinary urgency has not been revealed, although it has been speculated that it is involved in the abnormality in the afferent transmission. One has noted the significance on the role of unmyelinated C-fibers in which vanilloid receptors (VR1, VRL1) are largely expressed under pathologic conditions such as spinal cord injury, while the essence of mechanoceptors which convey urinary sensations is unknown. The recent studies demonstrated that the urothelium produced transmitters including ATP, influencing the transmission in the bladder sensory (Fry, C.H. : Urology, 2004). Thus, we examined the epithelial sodium channel (ENaC), one of th … More e candidates involved in the mechanosensory transduction in the bladder.Materials and Methods :1)Study in the human : Urothelia from patients without bladder outlet obstruction and with benign prostatic hyperplasia presenting OAB symptoms, were used. The expression of ENaC proteins was examined by immunohistofluorescent staining using anti-ENaC subunit polyclonal antibodies, and the ENaC genes expression was assessed by a quantitative RT-PCR.2)Study in the rat (in vitro) : Urothelia from female rats without bladder outlet obstruction and with partial urethral obstruction, were used. The expression of ENaC proteins was examined by immunohistofluorescent staining using anti-ENaC subunit polyclonal antibodies, and the ENaC genes expression was assessed by a quantitative RT-PCR.3)Study in the rat (in vivo) : Detrusor contractility and intermicturition interval were evaluated during cystometry. The effects of amiloride, an ENaC inhibitor, on these parameters were also examined.Results :1)Study in the human : The expression of proteins for ENaC subunits (α, β, γ) was detected in the human urinary bladder. The expression levels of each ENaC subunit mRNA in obstructed bladders were significantly greater than those in controls (Urology, 64 : 1255-1260, 2004).2)Study in the rat (in vitro) : The expression of proteins for ENaC subunits (α, β, γ) was detected in the rat urinary bladder, although the expression levels of each subunit mRNA were not quantitatively different between bladders with and without bladder outlet obstruction3)Amiloride, an ENaC inhibitor, did not change the detrusor contractility, whereas it markedly increased the intermicturition interval.Conclusions and Discussion :The studies revealed a remarkable species difference between the human and rat bladders with obstructed urethra in the expression levels of ENaC subunits (α, β, γ) mRNA, while these suggested the possibility that ENaC was involved in the induction of overactive bladder. Less
膀胱过度活动症(Overactive bladder,OAB)是2002年国际尿失禁学会(International Continence Society)最新定义的一种以排尿为基础的综合征,是以尿急为主要症状的储尿功能障碍。引起尿急的机制尚未被揭示,尽管已经推测其参与传入传递的异常。人们已经注意到无髓鞘C纤维的作用的重要性,其中香草酸受体(VR 1,VRL 1)在病理条件下如脊髓损伤时大量表达,而传递泌尿感觉的机械感受器的本质尚不清楚。最近的研究表明,尿道分泌物产生包括ATP的递质,影响膀胱感觉中的传递(Fry,C.H.:Urology,2004)。因此,我们检测了上皮钠通道(ENaC), ...更多信息 材料和方法:1)人体研究:采用无膀胱出口梗阻和良性前列腺增生患者的尿路上皮,表现为OAB症状。采用荧光染色法检测ENaC蛋白的表达,RT-PCR法检测ENaC基因的表达。2)体外实验:取无膀胱出口梗阻和部分尿道梗阻的雌性大鼠的尿道上皮细胞。采用荧光染色法检测ENaC蛋白的表达,RT-PCR法检测ENaC基因的表达。3)大鼠体内研究:膀胱测压法检测逼尿肌收缩力和排尿间期。结果:1)人体研究:在人膀胱中检测到ENaC亚基(α、β、γ)蛋白的表达。梗阻组ENaC各亚基mRNA表达水平均显著高于对照组(Urology,64:1255-1260,2004)。(体外):膀胱组织中ENaC亚单位(α、β、γ)蛋白表达,虽然在有和没有膀胱出口梗阻的膀胱中,每个亚单位mRNA的表达水平在数量上没有差异。3)Amiloride,一种ENaC抑制剂,不改变逼尿肌收缩性,结论:ENaC亚单位(α,β,γ)mRNA在尿道梗阻的人和大鼠膀胱中的表达存在明显的种属差异,提示ENaC可能参与了膀胱过度活动症的发生。少

项目成果

期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeda M, Araki I, Kamiyama M, Takihana Y, Komuro M, Furuya Y: "Diagnosis and treatment of voiding symptoms"Urology. 62, suppl 2. 11-19 (2003)
Takeda M、Araki I、Kamiyama M、Takihana Y、Komuro M、Furuya Y:“排尿症状的诊断和治疗”泌尿外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lower urinary tract symptoms in men and women without lower urinary tract diseases: natural history of bladder function.
无下尿路疾病的男性和女性的下尿路症状:膀胱功能的自然史。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Araki I;Takeda M
  • 通讯作者:
    Takeda M
過活動膀胱症候群治療薬をスクリーニングするために用いる標的物質、及び過活動膀胱症候群治療薬
用于筛选膀胱过度活动症候群疗法的目标物质及膀胱过度活动症候群疗法
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Incontinence
  • DOI:
    10.1016/j.mcna.2011.02.006
  • 发表时间:
    2011-05-01
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Markland, Alayne D.;Vaughan, Camille P.;Goode, Patricia S.
  • 通讯作者:
    Goode, Patricia S.
Hiramatsu N, Kasai A, Yao J, Meng Y, Takeda M, Maeda S, Kitamura M: "AP-1-independent Sensitization of Oxidative Stress-induced Apoptosis by Proteasome Inhibitors"Biochem Biophys Res Com. 316. 545-552 (2001)
Hiramatsu N、Kasai A、Yao J、Meng Y、Takeda M、Maeda S、Kitamura M:“蛋白酶体抑制剂对氧化应激诱导的细胞凋亡的 AP-1 独立敏感性”Biochem Biophys Res Com。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEDA Masayuki其他文献

TAKEDA Masayuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEDA Masayuki', 18)}}的其他基金

Mechanism of driver mutation positive lung cancer
驱动突变阳性肺癌发生机制
  • 批准号:
    15K21525
  • 财政年份:
    2015
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Studies on lower urinary tract dysfunction pathogenesis by complex systems network and dynamic homeostasis collapse
复杂系统网络和动态稳态崩溃对下尿路功能障碍发病机制的研究
  • 批准号:
    15H04972
  • 财政年份:
    2015
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on vesicular type transporter and refractory lower urinary tract dysfunction
囊泡型转运蛋白与难治性下尿路功能障碍的研究
  • 批准号:
    26670699
  • 财政年份:
    2014
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanisms And Possible Novel Treatments for Nocturiarelated to Abnormal Circadian Rhythm
与昼夜节律异常相关的夜尿症的机制和可能的新疗法
  • 批准号:
    23659754
  • 财政年份:
    2011
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Teaching Materials and Tools for Education of Information Science for Elementary, Junior High and High School Students
中小学生信息科学教育教材与工具
  • 批准号:
    23650515
  • 财政年份:
    2011
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Research on the afferent transduction in the lower urinary tract
下尿路传入传导的研究
  • 批准号:
    23390381
  • 财政年份:
    2011
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Foundational technology for light-weight XML-DBMS based on very fast compressed data stream processing
基于极快压缩数据流处理的轻量级 XML-DBMS 基础技术
  • 批准号:
    22300010
  • 财政年份:
    2010
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Reseaarch on the function and development of new therapy for Ion channels in the lower urinary tract
下尿路离子通道的功能研究及新疗法的开发
  • 批准号:
    20390423
  • 财政年份:
    2008
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Key Technology for XML DB in Embedded Device Based on Efficient Compressed Pattern Matching
基于高效压缩模式匹配的嵌入式XML数据库关键技术
  • 批准号:
    19300008
  • 财政年份:
    2007
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of efficient machine discovery system based on data compression and pattern matching
基于数据压缩和模式匹配的高效机器发现系统的开发
  • 批准号:
    15300049
  • 财政年份:
    2003
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

Cannabinoid信号系统对视网膜内网状层细胞突触传递调控的机制研究
  • 批准号:
    30870803
  • 批准年份:
    2008
  • 资助金额:
    38.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting Cannabinoid Receptors in HER2 positive tumours.
靶向 HER2 阳性肿瘤中的大麻素受体。
  • 批准号:
    2892094
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Studentship
Cannabinoid type 2 receptors as a therapeutic target for substance use disorders
大麻素 2 型受体作为物质使用障碍的治疗靶点
  • 批准号:
    10606224
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
阐明艾滋病毒和大麻素暴露期间神经源性大脑区域的单细胞变化
  • 批准号:
    10686685
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Contributions of astrocytic cannabinoid type-1 receptors (CB1R) to metabolic dysfunction in mild traumatic brain injury
星形细胞大麻素 1 型受体 (CB1R) 对轻度创伤性脑损伤代谢功能障碍的影响
  • 批准号:
    495555
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Miscellaneous Programs
2023 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar
2023中枢神经系统戈登研究会议和戈登研究研讨会大麻素功能
  • 批准号:
    10683605
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Investigating the role of cannabinoid receptors in oligodendrocyte development
研究大麻素受体在少突胶质细胞发育中的作用
  • 批准号:
    10605105
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Glutamatergic plasticity that drives cannabinoid withdrawal and craving
谷氨酸可塑性导致大麻素戒断和渴望
  • 批准号:
    10743526
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
The role of Cannabinoid Receptor 2 in cerebrovascular protection following traumatic brain injury
大麻素受体2在脑外伤后脑血管保护中的作用
  • 批准号:
    10607700
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Kratom and Cannabinoid Constituents: Mechanisms and Interactive Effects in Neuropathic Pain
卡痛和大麻素成分:神经性疼痛的机制和相互作用
  • 批准号:
    10745835
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
The regulation of renal tubular transport by cannabinoid receptor type 1 (CB1R) and its endogenous lipid ligands
1型大麻素受体(CB1R)及其内源性脂质配体对肾小管转运的调节
  • 批准号:
    10588113
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了